By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in antibiotic resistance.
Review of data from the trial found that the vaccine was not sufficiently effective at preventing invasive E coli disease ...
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...
Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...
5d
Hosted on MSNThe Antibiotic Arms Race: Can Science Stay Ahead of Rapidly Evolving Antibiotic-Resistant Bacteria?A study reveals alarming rates of antibiotic resistance in Gram-negative bacteria, highlighting the urgent need for ...
5d
Pharmaceutical Technology on MSNFDA approves AbbVie’s Emblaveo for intra-abdominal infectionsAbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.
The virus struck more layer and other commercial poultry farms, as well as backyard flocks in multiple states.
AbbVie announced that the US FDA has approved aztreonam and avibactam (Emblaveo), in combination with metronidazole, for ...
A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: ...
The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...
CAMBRIDGE, MA AND PITTSBURGH, PA / ACCESS Newswire / February 10, 2025 / Next Gen Diagnostics (NGD), a pioneer in the development of machine learning models for whole genome sequence- (WGS-) based det ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results